Reimbursement Conference Compendium

Reimbursement Compendium

Conferences

The perspective of the decision maker in healthcare affects the meaning of value and the US healthcare system is still trying to figure out how to measure value, said Darius Lakdawalla, PhD, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the School of Pharmacy at the University of Southern California.
A one-size-fits-all approach to value is impossible in the US healthcare system, but a pluralistic approach is extremely complex to implement, says Ilene Hollin, PhD, MPH, the National Pharmaceutical Council and University of Southern California Schaeffer Center’s Postdoctoral Health Policy Fellow.
Michael Sherman, MD, chief medical officer at Harvard Pilgrim Health Care, discusses how Harvard Pilgrim uses value framework during formulary deliberations to help make decisions, despite the fact that they only cover certain disease states right now.
Value-based purchasing is happening and Glytec is participating in this new and transitioning form of care, says Andrew Rhinehart, MD, chief medical officer at Glytec. This extension of care beyond the hospital for diabetes needs is promising in producing better patient outcomes.
Patients, payers, and providers all view value in different ways, and they all need to be taken into account in value frameworks, said Ilene Hollin, PhD, MPH, the National Pharmaceutical Council and University of Southern California Schaeffer Center’s Postdoctoral Health Policy Fellow.
Performance-based risk-sharing agreements don't just provide cost savings for physicians and payers, but they help to add another element of negotiation among pharmaceutical companies, explained Michael Sherman, MD, chief medical officer at Harvard Pilgrim Health Care.
Medical bankruptcy is indefensible and even if patients are willing to bankrupt themselves to purchase a cure, doesn't mean that is how pricing and reimbursement of treatments should be handled, said Darius Lakdawalla, PhD, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the School of Pharmacy at the University of Southern California
Compendia
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
$AD300x250BB$
$vacMongoViewPlus$